Overview

Orlistat Treatment of Crigler-Najjar Disease

Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine whether orlistat is effective in decreasing plasma unconjugated bilirubin levels in patients with Crigler-Najjar disease.
Phase:
N/A
Details
Lead Sponsor:
University Medical Center Groningen
Collaborators:
De Najjar Stichting
Erasmus Medical Center
Treatments:
Orlistat